Antimicrobial Use Guidelines (AMUG) version 21 - UW Health

References:1. Mora-Duarte J. Betts R. Rotstein C. Colombo AL. Thompson-Moya L. Smietana J.Lupinacci R. Sable C. Kartsonis N. Perfect J. Caspofungin Invasive Candidiasis StudyGroup. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl JMed 2002; 347(25):2020-9.2. Deresinski SC. Stevens DA. Caspofungin. Clin Infect Dis 2003; 36(11):1445-57.3. Bennett JE. Echinocandins for candidemia in adults without neutropenia. N Engl J Med2006;355:1154-1159.4. Phillips P. Shafran S. Garber G. Rotstein C. Smaill F. Fong I. Salit I. Miller M. Williams K.Conly JM. Singer J. Ioannou S. Multicenter randomized trial of fluconazole versusamphotericin B for treatment of candidemia in non-neutropenic patients. CanadianCandidemia Study Group. Eur J Clin Microbiol Infect Dis 1997;16(5):337-45.5. Rex JH. Bennett JE. Sugar AM. Pappas PG. van der Horst CM. Edwards JE. WashburnRG. Scheld WM. Karchmer AW. Dine AP. et al. A randomized trial comparing fluconazolewith amphotericin B for the treatment of candidemia in patients without neutropenia.Candidemia Study Group and the National Institute. N Engl J Med 1994; 331(20):1325-30.6. Pfaller MA. Diekema DJ. Jones RN. Sader HS. Fluit AC. Hollis RJ. Messer SA. SENTRYParticipant Group. International surveillance of bloodstream infections due to Candidaspecies: frequency of occurrence and in vitro susceptibilities to fluconazole,ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in theSENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39(9):3254-9.7. Bodey GP. Mardani M. Hanna HA. Boktour M. Abbas J. Girgawy E. Hachem RY.Kontoyiannis DP. Raad II. The epidemiology of Candida glabrata and Candida albicansfungemia in immunocompromised patients with cancer. Am J Med 2002;112(5):380-5.8. Wingard JR. Merz WG. Rinaldi MG. Johnson TR. Karp JE. Saral R. Increase in Candidakrusei infection among patients with bone marrow transplantation and neutropeniatreated prophylactically with fluconazole. N Engl J Med 1991;325(18):1274-7.9. Ostrosky-Zeichner L. Oude Lashof AM. Kullberg BJ. Rex JH. Voriconazole salvagetreatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis 2003;22:651-5.10. Dupont B. Overview of the lipid formulations of amphotericin B. Journal of AntimicrobChemother 2002;49 Suppl 1:31-6.11. Herbrecht R. Denning DW. Patterson TF. Bennett JE. Greene RE. Oestmann JW. KernWV. Marr KA. Ribaud P. Lortholary O. Sylvester R. Rubin RH. Wingard JR. Stark P.Durand C. Caillot D. Thiel E. Chandrasekar PH. Hodges MR. Schlamm HT. Troke PF. dePauw B. Invasive Fungal Infections Group of the European Organisation for Researchand Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versusamphotericin B for primary therapy of invasive aspergillosis. N Engl J Med2002;347(6):408-15.12. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA,Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ. Efficacy andSafety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to orIntolerant of Conventional Antifungal Therapy. Clin Infect Dis 2004;39:1563-71.13. Kirkpatrick WR. Perea S. Coco BJ. Patterson TF. Efficacy of Caspofungin alone and incombination with voriconazole in a Guinea pig model of invasive aspergillosis. AntimicrobAg Chemother 2002;46(8):2564-8.14. Perea S. Gonzalez G. Fothergill AW. Kirkpatrick WR. Rinaldi MG. Patterson TF. In vitrointeraction of Caspofungin acetate with voriconazole against clinical isolates ofAspergillus spp. Antimicrob Ag Chemother 2002;46(9):3039-41.15. Petraitis V. Petraitiene R. Sarafandi AA. Kelaher AM. Lyman CA. Casler HE. Sein T. GrollAH. Bacher J. Avila NA. Walsh TJ. Combination therapy in treatment of experimentalpulmonary aspergillosis: synergistic interaction between an antifungal triazole and anechinocandin.[comment]. J Infect Dis 2003;187(12):1834-43.16. Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy forinvasive aspergillosis. Clin Infect Dis 2004;39:797-802.